AstraZeneca Pays Texas $110M For Off-Label Marketing Of Seroquel, Crestor
AUSTIN, Texas — AstraZeneca LP has agreed to pay $110 to resolve two Texas state Medicaid fraud lawsuits for the wrongful promotion of the antipsychotic drug Seroquel and the statin drug...To view the full article, register now.
Already a subscriber? Click here to view full article